Patients The rise of prescription drug abuse and drug diversion As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased.
Views & Analysis Lilly’s Mounjaro wins latest head-to-head battle in clinical... Diabetes is one of the most common health conditions in the United States, afflicting more than 11% of the population, with over 90% included in the type 2 category.
News Azithromycin for mild-to-moderate COVID-19 Azithromycin has been widely evaluated for its efficacy against COVID-19.
Partner Content Partner Content Customer experience: shaping digital healthcare How pharma is using modern tech to improve treatment
Partner Content Partner Content Understanding Multiple Sclerosis Informative downloadable pack on Multiple Sclerosis
Partner Content Partner Content Patient Organisations role in Orphan Drugs clinical developm... Orphan Drugs and Rare Diseases Conference - London
News 23andMe stock sell-off adds to its woes Shares in genetic testing company 23andMe continue to slide after prominent investors announce plans to sell their stakes
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends